July/August 2016

This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.

Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.

This study highlights the implications of noncompliance with the use of in-network providers for immunization services, shedding light on value-based benefits design to promote access to recommended vaccinations.

Specialty-focused partial-fill plan designs are gaining traction, with conflicting opinions on whether they reduce waste or impact the quality of care.

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.

This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.

The development and implementation of a rare disease management program by healthcare providers and payors could greatly assist in improving the clinical, psycho-social and economic impacts for this patient population.

The pharmacoeconomic impact of treating acute gout flares with ColciGel or with oralcolchicine.